Thrive’s CancerSEEK uses blood tests for early multi-cancer detection
Endpoints News - 28-Apr-2020Demonstrated in a large prospective study involving patients without cancer history
Join the club for FREE to access the whole archive and other member benefits.
Biotechnology company, Massachusetts
Thrive Earlier Detection, our goal is to transform this outlook: to catch cancer earlier, when it can be more effectively treated. We are developing CancerSEEK, a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages. Our approach goes beyond a cancer diagnosis. We are developing a platform that will serve as a resource to help patients and their families maneuver the often confusing and overwhelming path that follows a cancer diagnosis.
Visit website: https://thrivedetect.com/
Details last updated 02-May-2020
Demonstrated in a large prospective study involving patients without cancer history